Antifungal activity of plumericin and isoplumericin

Natural Product Communications

Volumn 6, Issue 11, 2011, Pages 1567-1568

  Singh, Dharmendra ^a   Sharma, Umakant ^a   Kumar, Parveen ^a   Gupta, Yogesh K ^b   Dobhal, M P ^b   Singh, Sarman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Candidiasis; Cryptococcosis; Isoplumericin; Plumeria bicolor; Plumericin

Indexed keywords

ANTIFUNGAL AGENT; CHLOROFORM; ISOPLUMERICIN; NYSTATIN; PLUMERICIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; IN VITRO STUDY; MINIMUM FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOLOGICAL PARAMETERS;

EID: 82455184393     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1100601101     Document Type: Article

References (18)

1. (a) McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. (2001) Trends in mortality due to invasive mycotic diseases in United States, 1980-1997. Clinical Infectious Diseases, 33, 641-647;
2. (b) De Paiva SR, Figueiredo MR, Aragao TV, Kaplan MAC. (2003) Antimicrobial activity in vitro plumbagin isolated from Plumbago species. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, 98, 956-961;
3. (c) Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. (2003) Natural history of human immunodeficiency virus disease in Southern India. Clinical Infectious Diseases, 36, 79-85.
4. Satishchandra P, Mathew T, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A, Shankar SK. (2007) Cryptococcal meningitis: clinical, diagnostics and therapeutic overview. Neurology India, 55, 226-232.
5. (a) Lachoria L, Jain PC, Agrawal SC. (1999) Activity of some plant extracts against dermatophytes. Hindustan Antibiotics Bulletin, 41, 17-21;
6. (b) Rates SMK. (2001) Plants as source of drugs. Toxicon, 39, 603-613.
7. (a) Dobhal MP, Li G, Gryshuk A, Graham A, Bhatanager AK, Khaja SD, Joshi YC, Pandey RK. (2004) Structural modifications of plumieride isolated from Plumeria bicolor and the effect of these modifications on in vitro anticancer activity. Journal of Organic Chemistry, 69, 6165-6172;
8. (b) Gupta RS, Bhatnager AK, Joshi YC, Sharma R, Sharma A. (2004) Effects of Plumieride, an iridoid on spermatogenesis in male albino rats. Phytomedicine, 11, 169-174. (Pubitemid 38314058)
9. (a) Coppen JJW. (1983) Iridoids with algicidal properties from Allamanda. Phytochemistry, 22, 179-182;
10. (b) Castillo D, Arevalo J, Herrera F, Ruiz C, Rojas R, Rengifo E, Vaisberg A, Lock O, Lemesre JL, Gornitzka H, Sauvain M. (2007) Spirolactone iridoids might be responsible for the anti-leishmanial activity of a Peruvian traditional remedy made with Himatanthus sucuuba (Apocynaceae). Journal of Ethnopharmacology, 112, 410-414;
11. (c) Kupchan SM, Giacobbe TJ, Krull JS, Thomas AM, Eakin MA, Fessler DC. (1970) Reaction of endocyclic αiquest;, β-unsaturated lactones with thiols. Journal of Organic Chemistry, 35, 3539-3543.
12. Wood CA, Lee K, Vaisberg AJ, Kingston DGI, Neto CC, Hammond GB. (2001) A bioactive spirolactone iridoid and triterpenoids from Himatanthus sucuuba. Chemical & Pharmaceutical Bulletin, 49, 1477-1478. (Pubitemid 33043282)
13. Montero-Torres A, Vega MC, Marrero-Ponce Y, Rolon M, Gomez-Barrio A, Escario JA, Aran VJ, Martínez-Fernández AR, Meneses-Marcel A. (2005) A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds. Bioorganic & Medicinal Chemistry, 13, 6264-6275. (Pubitemid 41400149)
14. Stephens PJ, Pan JJ, Devlin FJ, Krohn K, Kurtan T. (2007) Determination of the absolute configurations of natural products via density functional theory calculations of vibrational circular dichroism, electronic circular dichroism, and optical rotation: the iridoids plumericin and isoplumericin. Journal of Organic Chemistry, 72, 3521-3536. (Pubitemid 46668155)
15. Abdel-Kader MS, Wisse J, Evans R, van der Werff H, Kingston DGI. (1997) Bioactive iridoids and a new lignan from Allamanda cathartica and Himatanthus fallax from the Suriname rainforest. Journal of Natural Products, 60, 1294-1297. (Pubitemid 28030253)
16. Abdel-Kader MS, Wisse J, Evans R, van der Werff H, Kingston DGI. (1997) Bioactive iridoids and a new lignan from Allamanda cathartica and Himatanthus fallax from the Suriname rainforest. Journal of Natural Products, 60, 1294-1297. (Pubitemid 28030253)
17. De Sá Barretoa A, De Carvalhoa MG, De Almeida Nerya I, Gonzaga L, Kaplan MAC. (1998) Chemical Constituents from Himatanthus articulata. Journal of Brazilian Chemical Society, 9, 430-434.
18. National Committee for Clinical Laboratory Standards. (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard NCCLS document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.